✦ LIBER ✦

CD4+ T cells in antitumor immunity: utility of an Ii-Key HER2/neu hybrid peptide vaccine (AE37)

✍ Scribed by Mittendorf, Elizabeth A; Holmes, Jarrod P; Murray, James L; von Hofe, Eric; Peoples, George E

Book ID: 115453159
Publisher: Informa plc
Year: 2008
Tongue: English
Weight: 318 KB
Volume: 9
Category: Article
ISSN: 5847-4714
DOI: 10.1517/14712590802614538

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Circulating regulatory T cells (CD4+CD25

Circulating regulatory T cells (CD4+CD25+FOXP3+) decrease in breast cancer patients after vaccination with a modified MHC class II HER2/neu (AE37) peptide

✍ Jeremy D. Gates; Guy T. Clifton; Linda C. Benavides; Alan K. Sears; Mark G. Carm 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 479 KB

Induction of potent CD4+ T cell-mediated

Induction of potent CD4+ T cell-mediated antitumor responses by a helper HER-2/neu peptide linked to the Ii-Key moiety of the invariant chain

✍ Ioannis F. Voutsas; Angelos D. Gritzapis; Louisa G. Mahaira; Maria Salagianni; E 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 471 KB

## Abstract The Ii‐Key fragment from the MHC class II‐associated invariant chain (or Ii protein) has been shown to facilitate direct charging of MHC class II epitopes to the peptide binding groove. The purpose of the present study was to test the potential of a series of Ii‐Key/HER‐2__/neu__(776–79

Identification of a regulatory T cell su

Identification of a regulatory T cell subset that correlates with in vivo and in vitro immune responses in breast cancer patients receiving a CD4-eliciting, HER2 peptide vaccine (AE37)

✍ Trappey, Alfred Francois; Berry, John S.; Mursal, Mohamed; Jama, Yusuf; Zacharia 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 49 KB